Success Metrics

Clinical Success Rate
91.7%

Based on 22 completed trials

Completion Rate
92%(22/24)
Active Trials
7(19%)
Results Posted
14%(3 trials)
Terminated
2(6%)

Phase Distribution

Ph not_applicable
7
19%
Ph phase_3
4
11%
Ph phase_2
8
22%
Ph phase_4
13
36%
Ph phase_1
4
11%

Phase Distribution

4

Early Stage

8

Mid Stage

17

Late Stage

Phase Distribution36 total trials
Phase 1Safety & dosage
4(11.1%)
Phase 2Efficacy & side effects
8(22.2%)
Phase 3Large-scale testing
4(11.1%)
Phase 4Post-market surveillance
13(36.1%)
N/ANon-phased studies
7(19.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.0%

22 of 25 finished

Non-Completion Rate

12.0%

3 ended early

Currently Active

7

trials recruiting

Total Trials

36

all time

Status Distribution
Active(7)
Completed(22)
Terminated(3)
Other(4)

Detailed Status

Completed22
Recruiting5
unknown4
Active, not recruiting2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
7
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (11.1%)
Phase 28 (22.2%)
Phase 34 (11.1%)
Phase 413 (36.1%)
N/A7 (19.4%)

Trials by Status

withdrawn13%
active_not_recruiting26%
recruiting514%
unknown411%
terminated26%
completed2261%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT04580563Not Applicable

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study

Completed
NCT07116343Phase 4

Intrapleural Ropivacaine Infusion in Cardiac Surgery

Recruiting
NCT07459413Not Applicable

Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED

Recruiting
NCT07404358Phase 3

Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery

Active Not Recruiting
NCT05851066Phase 1

A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers

Completed
NCT06713317Phase 1

A Phase I Study to Evaluate the Safety and Drug Allergy of HLB3-002 in Healthy Volunteers

Completed
NCT06930326Not Applicable

Exosome Treatment and Hair Growth

Completed
NCT05755997Phase 2

CERebrolysin In CADASIL

Active Not Recruiting
NCT06670963Phase 4

Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial

Recruiting
NCT06506565Phase 4

Low-Dose Ketamine Infusion During Burn Wound Care

Recruiting
NCT02636218Phase 2

Ketamine Infusion in Neurologic Deficit

Completed
NCT05412576Not Applicable

a Pilot Study of Lidocaine Infusion for Postoperative Analgesia in Elderly Patients With Colorectal Cancer Surgery

Completed
NCT04390646Phase 2

GnRH Therapy on Cognition in Down Syndrome

Recruiting
NCT05887479Phase 4

The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity

Withdrawn
NCT05922813Phase 1

Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj.

Completed
NCT05042817Not Applicable

Effect of Intrathecal Morphine on Urinary Bladder Function and Recovery in Patients Having a Cesarean Delivery

Completed
NCT04931628Not Applicable

Efficacy and Safety of Salvianolic Acid on AIS

Terminated
NCT01668277Phase 2

Effects of Saline on Circulation in Children

Terminated
NCT02974660Phase 4

Protamine Sulfate During Transcatheter Aortic Valve Implantation

Completed
NCT02807337Phase 2

Supersaturated Calcium Phosphate Oral Rinse (Caphosol®) For the Prevention of Oral Mucositis in Children Undergoing Chemotherapeutic Treatments

Completed

Drug Details

Intervention Type
OTHER
Total Trials
36